Portage Biotech Inc.
NASDAQ:PRTG
4.99 (USD) • At close January 7, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Portage Biotech Inc. |
Symbool | PRTG |
Munteenheid | USD |
Prijs | 4.99 |
Beurswaarde | 5,594,084 |
Dividendpercentage | 0% |
52-weken bereik | 2.1 - 25.6 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ian B. Walters M.B.A., M.D. |
Website | https://www.portagebiotech.com |
An error occurred while fetching data.
Over Portage Biotech Inc.
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)